Dong Chen, MD, PhD, discusses how AI has changed the landscape for genomic testing and patient management.
Dong Chen, MD, PhD
Advertisement
Dong Chen, MD, PhD, is a hematopathologist and vice chair of practice in pathology in the Department of Laboratory Science and Pathology at Mayo Clinic in Rochester, MN.
Articles by Dong Chen, MD, PhD
Dong Chen, MD, PhD, discusses the obstacles and opportunities for growth in posttreatment cancer detection.
Dong Chen, MD, PhD, discusses the most recent advancements in posttreatment cancer detection.
Advertisement
Latest Updated Articles
AI's Impact: Revolutionizing Patient Care and Medical TestingPublished: May 26th 2025 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
